Avilar Therapeutics is a pioneering brand that is revolutionizing the field of protein degradation. With a focus on both intracellular and extracellular targets, Avilar is at the forefront of developing innovative degraders to treat a variety of serious diseases. They are currently working on a groundbreaking class of degraders called ATACs (ASGPR Targeting Chimeras), which utilize a natural endogenous process for protein degradation.

By harnessing the power of the body's own degradation machinery, Avilar is able to create bespoke and modular drug solutions that target a wide range of extracellular proteins. With almost 40% of human proteins located outside the cell, Avilar's innovative approach holds immense potential for improving patient outcomes. If you're passionate about pushing the boundaries of science and value a respectful and inclusive working environment, Avilar Therapeutics invites you to join their team of bold thinkers